Profile of Ulcerative Colitis in a North Indian Hospital

Size: px
Start display at page:

Download "Profile of Ulcerative Colitis in a North Indian Hospital"

Transcription

1 ORIGINAL ARTICLE Profile of Ulcerative Colitis in a North Indian Hospital Ajit Sood*, Vandana Midha*, Neena Sood**, Sandeep Puri*, Vikas Kaushal* Abstract Background : The increasing prevalence of ulcerative colitis has been reported from Western countries. Even in India the disease is now being diagnosed more commonly. However, there is need to study the disease course and its associated complications from our country. Aim : To study the natural history, clinical profile and course of ulcerative colitis in India. Methodology : A hospital based study registering previously diagnosed and newly diagnosed cases of ulcerative colitis, was carried out from Ist January, 1993 to 31st December, The course and severity of the disease and response to treatment was monitored in all patients prospectively. The response to treatment was assessed as complete remission, partial remission, and relapse. Patients with irregular follow up were not included. Results : Out of a total of 148 registered patients, 120 patients on regular follow up were analysed. The average duration of symptoms prior to the entry was 2.7 years. Eighty eight (73.34%) had severe disease, 16 (13.34%) had moderate and 16 (13.34%) had mild disease at presentation. One hundred nine (90.84%) patients had episodic disease; none presented with acute fulminant colitis. Twenty one patients (17.5%) developed various complications. Conclusions : Ulcerative colitis was responsible for a hosital admission rate of 12/10,000. Most of the patients presented with severe disease as contrary to the previously reported literature from our country. Complications do occur but sinister complications like fulminant colitis and carcinoma are uncommon. Key Words : Ulcerative Colitis, Clinical Profile. Many studies have been published describing various aspects of the disease from Europe and the United States over the past 50 years. However, more data is required from India to study the disease course in our country. The earlier studies reported from India suggested low incidence of the disease and a milder disease pattern. However, subsequent reports in the late nineties have reported a more aggressive course of the disease. Also, an increased incidence has been reported probably reflecting increased awareness, availability of better facilities for diagnosis or truly increased incidence. The present report assesses the magnitude of the disease in a tertiary medical centre in North India and studies its natural history, course, and clinical profile. Materials and Methods A hospital based registration of previously * Unit of Gastroenterology, Departments of Medicine and Pathology**, Dayanand Medical College and Hospital, Ludhiana , Punjab established as well as newly diagnosed cases of ulcerative colitis was carried out from Ist January, 1993 to 31st December, Ulcerative colitis was diagnosed on the basis of clinical picture, failure to isolate known bacterial and protozoal pathogens on stool examination, sigmoidoscopy and histological findings supporting the diagnosis. The treatment principles were generally homogenous, maintenance therapy with sulfasalazine (4-6 gm) or 5-aminosalicylic acid (5-ASA) and glucocorticoids for flare-up episodes, administered orally for periods of weeks. Patients who had severe disease and required hospitalization were treated with parenteral steroids initially alongwith antimicrobials - ciprofloxacin and metronidazole. In cases of failure of medical therapy, the patients were evaluated for surgery. Patients were followed-up for their disease course as relapse, partial remission or complete remission. Relapse was defined as worsening of symptoms recognised by the patient (rectal bleeding, loose stools and bowel frequency) with sigmoidoscopic appearance of active colitis

2 (granularity, friability and/or spontaneous bleeding). Complete remission was defined as clinical improvement with absence of symptoms of active disease (rectal bleeding, stool frequency) with a sigmoidoscopic appearance of grade 0 or 1 (Baron et al : 0-normal mucosa, 1-granular oedematous mucosa with loss of vascular pattern, 2-bleeding to light touch, 3-spontaneous bleeding). Partial remission was defined as clinical improvement with stool frequency still more but less than 50% of previous, and sigmoidoscopy showing downgrading of severity (grade 1-2). Complications were evaluated as local and systemic. Results During the five year study period a total of 148 patients were registered, out of which 120 who were on regular follow-up were analysed. Mean follow up for the patients was 3.4 ± 1.6 year within a minimum follow up of 2 years for each patient. The maximum number of patients were in the age group of years (65%). The mean age at onset of disease was years in men and 32.9 years in women. Males were affected slightly more than females, the ratio being 1.04:1. The average duration of symptoms prior to the hospital entry was 2.7 years. Fifty eight patients (48.34%) had a disease duration of less than 2 years, 30 (25%) had 2-5 years, 22 (18.34%) had 5-10 years and 10 (8.34%) had disease of more than 10 years. On the basis of criteria of Truelove and Witt, 78 (65%) had severe disease, 24 (20%) had moderate and 18 (15%) had mild disease at presentation. Clinical Presentation Majority of the patients presented with intestinal symptoms like chronic diarrhoea (n=95) and/or rectal bleeding (n=80). The presentation with predominant extraintestinal manifestations, like joint pains(1), pyrexia of unknown origin(4), sclerosing cholangitis(2), was uncommon. These patients admitted to history of diarrhoea off and on but never of the magnitude requiring medical aid. The patients of pyrexia of unknown origin did not have any evidence of intraabdominal or perianal abscesses suggesting that disease activity was the cause of fever. Arthritis in our patients was polyarticular involving small and medium sized joints. The striking feature was the episodic presentation of arthritis with prolonged periods of spontaneous relief. Two patients who presented with sclerosing cholangitis were specifically investigated and found to have inflammatory bowel disease. One patient presented with two months history of diarrhoea with bleeding per rectum and was found to have colitis and carcinoma of sigmoid colon simultaneously. There was no past history of diarrhoea. Course One hundred and nine (90.81%) cases had episodic disease with remissions and relapses. Eleven (9.18%) had chronic continuous course and none presented with acute fulminant colitis requiring surgery at the presentation itself. The cumulative relapse rate between the time of registration and minimum follow-up of 2 years was 123. Hence the number of relapses per patient was 1.2/year. During the follow up, 51 patients (42.86%) had more than 2 relapses and 11 (9.18%) had a chronic relapsing course (more than 5 relapses) per year. Fourteen patients (12.25%) remained in remission for more than two years. Various factors incriminated by patients as precipitating cause for relapse were emotional disturbances like family feuds, death of family member (n=8), academic examination (n=6), dietary factors (n=12), pregnancy (n=2), seasonal variations (n=4), infections (n=4) and use of drugs (n=6). Ten patients underwent proctocolectomy due to refractoriness to medical therapy (n=6), carcinoma (n=3) and life threatening haemorrhage (n=1). One patient who refused surgery died due to refractoriness to medical therapy. Endoscopic Findings At presentation all the patients had grade II-III Journal of Indian Academy of Clinical Medicine Vol. 5 No

3 disease. The extent of the disease was proctosigmoiditis in 30 (25%), left sided in 57 (47.5%) and pancolitis in 33 (27.5%). Pseudopolypi were seen in 20 patients (16.67%). Complications Toxic megacolon and severe haemorrhage were seen in 2 patients each. One patient had pneumatosis cystoides intestinalis. He was diagnosed as ulcerative colitis 3 months back and again presented with fever and mild diarrhoea. His X-ray chest showed large amount of air under both domes of diaphragm. Barium studies showed changes of ulcerative colitis but no evidence of perforation. He did well on oral steroids and the peritoneal air disappeared. Carcinoma was detected in 4 cases. One patient had presented with colitis and carcinoma synchronously. The other two patients had a mean duration of disease of 10 years. One patient had a chronic disease of 15 years with total colectomy and ileorectal anastomosis done 8 years back. He had persistence of symptoms and on sigmoidoscopy rectum showed active proctitis with mass lesion. Systemic complications included arthralgias in 7 patients and arthritis in 3. Two patients had sclerosing cholangitis. No patient had pyoderma gangrenosum, erythema nodosum or eye involvement. Discussion Ulcerative colitis is a common disease in most of the industrialized countries in the world. The highest incidence is reported from Scandinavian countries and Scotland followed by England and North America 1-6. It was thought to be uncommon in the developing countries 7-9 but field studies to know the true prevalence are not available. In India, the diagnosis of ulcerative colitis is made with some diffidence on account of high incidence of dysenteric disorders. Almost 60 years ago Chopra and Ray (1939) had reported 120 cases of nonspecific ulcerative colitis which surprisingly went unnoticed in subsequent literature, leaving one to believe that ulcerative colitis is rare in this country 10. However, subsequently Tandon et al in published a series of ulcerative colitis dispelling the exisiting myth. An epidemiologic survey conducted in the general population in Northern India 12 also revealed a profile almost similar to that of the west but still large field studies are required from our country to find out the true incidence and point prevalence of the disease. In a study reported 30 years ago from a North Indian hospital, the hospital admission rate was shown as 9.4 per 10,000 admissions 13. The present study shows a higher hospital admission rate (12 per 10,000). This is similar to reported admission rate of 10 cases per 10,000 hospital admissions in the United Kingdom. Comparable figures from USA are , Switzerland 6 and Norway 5 per 10,000 hospital admissions 14. The clinical picture as observed in the present series is almost similar to the one widely described in the literature from the western countries. The disease was severe (by Truelove and Witts criteria) in majority of patients (65%), a pattern which is contrary to the belief that ulcerative colitis in India runs a mild course 13,15,16. This may reflect a changing pattern of the disease here. This pattern is quite similar to the one reported from west. However, the disease course reported in Indian immigrants to England and Durban is mildmoderate on clinical presentation 17,18. In the West there was a variance in the severity reported in epidemiological studies and hospital based studies. None of the patients presented with acute fulminant colitis in our study, though on subsequent course, two patients required surgery due to this complication. Its incidence in the western series is reported to be from 5-8%. Half of the patients in this study had left sided colitis (47.5%) with proctosigmoiditis in 25% and pancolitis in 27.5%. In one of the latest reviews from the West, 46% had proctosigmoiditis, 17% left sided colitis and 37% had pancolitis 19. The course of the disease was characterized by relapses and remission in majority (90%) with only 10% pursuing a chronic continuous course. The 126 Journal of Indian Academy of Clinical Medicine Vol. 5 No. 2

4 cumulative relapse rate was 1.2 per patient per year. The clinical response to glucocorticoids was generally very dramatic at the first use of the drug while patients, who had chronic active disease showed less prompt response. If steroids were tapered off very quickly the relapse rate was higher and hence, once started steriods should be tapered gradually over weeks. In our country, drug compliance cannot be ensured as patients have a tendency to omit or reduce drugs on their own once the symptomatic recovery occurs. Proper awareness of the disease is required to ensure compliance. Nearly 45% of the patients suffered from relapse within one year of disease diagnosis. The relapse may be set off by many factors and attention needs to be focussed on the identification of the cause to optimise the management of the individual. Kochhar et al in 1993 reported infectious agents especially Clostridium difficile, to be the cause of acute exacerbations. This is in contrast with the findings in developed countries 20. Hence in a tropical country like ours infectious agents should be specifically looked for and treated. The complication rate was less (17.5%) as compared to the reports of 31-40% 14 from western countries. Four cases of colitis carcinoma were detected during the study period. Variable reports are available from our country regarding colitis cancer. Some consider it distinctly rare 21 whereas others recommend cancer surveillance as it is not a rare entity 22. A very high incidence is reported from Mount Sinai Hospital, New York, St. Mark's Hospital, London and Birmingham, UK 21. Complications like erythema nodosum and pyoderma gangrenosum were absent. No patient had eye symptoms though we did not do slit lamp examination. Seven percent patients had arthralgias and approximately 3% had arthritis. Patients in our study have far less systemic complications as compared to what is recognised in the west and some Indian studies 23,24. In conclusion, the present study gives an overview of the present disease status of ulcerative colitis in our country. The patients generally reach hospital after prolonged symptomatology and have severe disease. Nearly two third of the patients have left sided disease or pancolitis. Though local complications are seen frequently but sinister complications like perforation, haemorrhage, toxic megacolon are not common. Carcinoma does remain a dreaded complication and regular follow up is mandatory in patients with long history of disease even when they are symptom free. References 1. Whelan G. Epidemiology and inflammatory bowel disease. Med Clin North Am 1990; 74: Kildebo S, Nordgaard K, Aronsen O et al. The incidence of ulcerative colitis in Northern Norway from 1983 to Scand J Gastroenterol 1990; 25: Langholz E, Munkholm P, Nielsen OH et al. Incidence and prevalence of ulcerative colitis in Copenhagen country from 1962 to Scand J Gastroenterol 1991; 26: Stonnington CM, Phillips SF, Melton LJ et al. Chronic ulcerative colitis : Incidence and prevalence in a community. Gut 1987; 28: Stowe SP, Redmond SR, Stormont JM et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 1990; 98: Ekbom A, Helmick C, Zack M et al. The epidemiology of inflammatory bowel disease : A large, population based study in Sweden. Gastroenterology 1991; 100: Mayberry JF. Crohn's disease in developing countries. Ital J Gastroenterol 1980; 12: Mayberry JF, Mann R. Inflammatory bowel disease in rural sub-saharan Africa : Rarity of diagnosis in patients attending mission hospitals. Digestion 1989; 44: Mendeloff AI, Calbins BM. The epidemiology of idiopathic inflammatory bowel disease. In : Kurner JB, Shorter NG, eds. Inflammatory bowel disease. Philadelphia : Lea and Febiger 1988; 3: Chopra RN, Ray PN. Indian Med Gas 1939; 74: Tandon BN, Mathur AK, Mohapatra LN et al. A study of the prevalence and clinical pattern of non-specific ulcerative colitis in northern India. Gut 1965; 6 (5): Khosla SN, Girdhar NK. Epidemiology of ulcerative colitis in the hospital and general population of Northern India. Ind J Gastroenterol 1989; 8 (4): (Suppl). 13. Chuttani HK, Nigam SP, Sama SK et al. Ulcerative colitis in the tropics. British Medical Journal 1967; 4: Journal of Indian Academy of Clinical Medicine Vol. 5 No

5 14. Bebchuk IO, Rogers AC, Downey JL. Chronic ulcerative colitis in a North American Indian. Gastroentology 1961; 40: Maroo MK, Nag NG, Sortartur SV et al. Ulcerative colitis in Southern Maharashtra. J Indian Med Assoc 1974; 63: Chuttani PN. Symposium on ulcerative colitis. J Asoc Physician India 1968; 16: Probert CS, Jayanthi V, Pinder D et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992; 33 (5): Rajput HI, Seebaran AR, Desai Y. Ulcerative colitis in the Indian population of Durban. South African Medical Journal 1992; 81 (5): Farmer RG, Easley KA, Rankin GB. Clinical pattern, natural history and progression of ulcerative colitis : A long term follow up of 116 patients. Dig Dis Sci 1993; 38: Kochhar R, Ayyagari A, Goenka MK et al. Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile. Journal of Clinical Gastroenterology 1993; 16 (1): Antia FP. Ulcerative colitis and cancer colon. Indian J Gastroenterol 1986; 5 (4): Kochhar R, Goenka MK, Kaushik SP et al. Colorectal carcinoma in Indian patients with idiopathic ulcerative colitis. European Journal of Cancer Prevention 1992; 1 (4): Kochhar R, Mehta SK, Nagi B et al. Extraintestinal manifestations of idiopathic ulcerative colitis. Indian J Gastroenterol 1991; 10 (3): Habeeb MA, Rajalingam R, Dhar A et al. HLA association and occurrence of autoantibodies in Asian Indian patients with ulcerative colitis. American J Gastroenterol 1997; 92 (5): Journal of Indian Academy of Clinical Medicine Vol. 5 No. 2

PROFILE OF ULCERATIVE COLITIS IN SOUTH INDIAN REGION: KARAIKAL D.BADMAPRIYA*, V.SATHISH KUMAR 1

PROFILE OF ULCERATIVE COLITIS IN SOUTH INDIAN REGION: KARAIKAL D.BADMAPRIYA*, V.SATHISH KUMAR 1 Page47 Available Online through IJPBS Volume 1 Issue 2 APRIL- JUNE 2011 PROFILE OF ULCERATIVE COLITIS IN SOUTH INDIAN REGION: KARAIKAL D.BADMAPRIYA*, V.SATHISH KUMAR 1 * PHARMACIST, GOVERNMENT GENERAL

More information

study was undertaken to assess the epidemiology, course and outcome of UC patients attending a hospital in Jordan.

study was undertaken to assess the epidemiology, course and outcome of UC patients attending a hospital in Jordan. Ulcerative colitis (UC) is a relatively uncommon, chronic, recurrent inflammatory disease of the colon or rectal mucosa [1]. Often a lifelong illness, the condition can have a profound emotional and social

More information

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic WHAT IS INFLAMMATORY BOWEL DISEASE (IBD)? Chronic inflammation of the intestinal tract Two related

More information

History of IBD in India

History of IBD in India History of IBD in India 1 History before History 1769 : Morgagni : gave the first description of Crohn s Disease 1865 : First description of Ulcerative colitis recorded in Annals of Union Army Medical

More information

Ulcerative Colitis: Experience at a Tertiary Care Center

Ulcerative Colitis: Experience at a Tertiary Care Center Original Article Ulcerative Colitis: Experience at a Tertiary Care Center Nasir Khokhar From Division of gastroenterology, Department of Medicine, Shifa International Hospital and Shifa College of Medicine,

More information

The Spectrum of IBD. Inflammatory Bowel Disease. Symptoms. Epidemiology. Tests for IBD. CD or UC? Inflamatory Bowel Disease. Fernando Vega, M.D.

The Spectrum of IBD. Inflammatory Bowel Disease. Symptoms. Epidemiology. Tests for IBD. CD or UC? Inflamatory Bowel Disease. Fernando Vega, M.D. The Spectrum of IBD Inflammatory Bowel Disease Fernando Vega, M.D. Epidemiology CD and UC together 1:400 UC Prevalence 1:500 UC Incidence 6-12K/annum CD Prevalence 1:1000 CD Incidence 3-6K/annum Symptoms

More information

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Predicting the natural history of IBD Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Patient 1 Patient 2 Age 22 Frequent cramps and diarrhea for 6 months Weight

More information

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease Aliment Pharmacol Ther 23; 18 (Suppl. 2): 1 5. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease P. MUNKHOLM Department of Medical Gastroenterology, Hvidovre

More information

NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente

NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND Fabrizio Parente Gastrointestinal Unit, A.Manzoni Hospital, Lecco & L.Sacco School of Medicine,University of Milan - Italy

More information

SURGICAL MANAGEMENT OF ULCERATIVE COLITIS

SURGICAL MANAGEMENT OF ULCERATIVE COLITIS SURGICAL MANAGEMENT OF ULCERATIVE COLITIS Cary B. Aarons, MD Associate Professor of Surgery Division of Colon & Rectal Surgery University of Pennsylvania AGENDA Background Diagnosis/Work-up Medical Management

More information

The variable risk of colorectal cancer in patients with inflammatory bowel disease.

The variable risk of colorectal cancer in patients with inflammatory bowel disease. The variable risk of colorectal cancer in patients with inflammatory bowel disease. Lindgren, Stefan Published in: European Journal of Internal Medicine DOI: 10.1016/j.ejim.2004.12.001 Published: 2005-01-01

More information

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

Inflammatory Bowel Disease When is diarrhea not just diarrhea? Inflammatory Bowel Disease When is diarrhea not just diarrhea? Jackie Kazik, MA, PA C CME Resources CAPA Annual Conference, 2011 Inflammatory Bowel Disease Objectives Discuss what is known about the pathophysiology

More information

Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA

Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA Endpoints Overview Hospitalization Surgery Colorectal cancer

More information

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency) CROHN S DISEASE Definitions Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency) Recurrence: The reappearance of lesions after surgical resection Endoscopic remission:

More information

PEDIATRIC INFLAMMATORY BOWEL DISEASE

PEDIATRIC INFLAMMATORY BOWEL DISEASE PEDIATRIC INFLAMMATORY BOWEL DISEASE Alexis Rodriguez, MD Pediatric Gastroenterology Advocate Children s Hospital Disclosers Abbott Nutrition - Speaker Inflammatory Bowel Disease Chronic inflammatory disease

More information

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine Crohn's disease Crohn's disease is an inflammatory condition of the digestive tract that affects children and adults. Common features of Crohn's disease include mouth sores, diarrhea, abdominal pain, weight

More information

Diarrhoea on the AMU. Dr Chris Roseveare

Diarrhoea on the AMU. Dr Chris Roseveare Diarrhoea on the AMU Dr Chris Roseveare The Society for Acute Medicine, Spring Meeting, Radisson Blu Hotel, Dublin 3-4 May 2012 Acute diarrhoea in developed countries adult populations Mainly a primary

More information

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.

More information

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology Patho Basic Chronic Inflammatory Bowel Diseases Jürg Vosbeck Pathology General Group of chronic relapsing diseases with chronic bloody or watery diarrhea Usually ulcerative colitis (UC) or Crohn s disease

More information

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis Screening for Colorectal Neoplasia in Inflammatory Bowel Disease Francis A. Farraye MD, MSc Clinical Director, Section of Gastroenterology Co-Director, Center for Digestive Disorders Boston Medical Center

More information

Ulcerative Colitis: State of the Art 2006

Ulcerative Colitis: State of the Art 2006 Ulcerative Colitis: State of the Art David T. Rubin, MD Assistant Professor of Medicine Inflammatory Bowel Disease Center University of Chicago Improving Management of Ulcerative Colitis (UC) Better classification/diagnostic

More information

Pouchitis and Cuffitis A bloody mess. Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board

Pouchitis and Cuffitis A bloody mess. Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board Pouchitis and Cuffitis A bloody mess Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board Ileal-pouch anal anastomosis https://www.pennmedicine.org/for-health-care-professionals/for-physicians/physician-education-and-resources/clinicalbriefings/2018/february/total-proctocolectomy-with-jpouch-reconstruction-for-ulcerative-colitis

More information

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease Management in South Africa in 2016 Pharmaceutical Care Management Association Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease

More information

GASTROENTEROLOGY. Official Publication of the American Gastroenterological Association. CoPYRIGHT 1975 THE WILLIAMS & WILKINS Co.

GASTROENTEROLOGY. Official Publication of the American Gastroenterological Association. CoPYRIGHT 1975 THE WILLIAMS & WILKINS Co. GASTROENTEROLOGY Official Publication of the American Gastroenterological Association CoPYRIGHT 1975 THE WILLIAMS & WILKINS Co. Vol68 April 1975 Number 4 ALIMENTARY TRACT CLINICAL PATTERNS IN CROHN'S DISEASE:

More information

Which is the Safest Strategy to Treat Moderate to Severe IBD?

Which is the Safest Strategy to Treat Moderate to Severe IBD? Which is the Safest Strategy to Treat Moderate to Severe IBD? David G. Binion, M.D. Co-Director, Inflammatory Bowel Disease Center Director, Translational Inflammatory Bowel Disease Research Visiting Professor

More information

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC ULCERATIVE COLITIS Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC What is Ulcerative Colitis? Ulcerative colitis (UC) is a disease marked by inflammation

More information

UNDERSTANDING ULCERATIVE COLITIS

UNDERSTANDING ULCERATIVE COLITIS UNDERSTANDING ULCERATIVE COLITIS START YOUR JOURNEY TOWARD UNDERSTANDING INFLAMMATORY BOWEL DISEASE CONTENTS INTRODUCTION 4 WHAT IS ULCERATIVE COLITIS? 6 Symptoms of ulcerative colitis 6 WHAT CAUSES ULCERATIVE

More information

Persistence of mucosal abnormality in ulcerative colitis

Persistence of mucosal abnormality in ulcerative colitis Gut, 966, 7, 55 Persistence of mucosal abnormality in ulcerative colitis A. P. DICK, L. P. HOLT', AND E. R. DALTON rom Addenbrooke's Hospital, Cambridge, and the Department of Human Ecology, University

More information

Surgical Treatment of Inflammatory Bowel Disease (IBD)

Surgical Treatment of Inflammatory Bowel Disease (IBD) Surgical Treatment of Inflammatory Bowel Disease (IBD) JMAJ 45(2): 55 62, 2002 Tetsuichiro MUTO Vice-Director, Cancer Institute Hospital Abstract: IBD, especially ulcerative colitis (UC) and Crohn s disease

More information

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type. Surg Clin N Am 87 (2007) 787 796 Index Note: Page numbers of article titles are in boldface type. A Abscesses in anorectal Crohn s disease, 622 intra-abdominal, in Crohn s disease, 590 591 perirectal,

More information

INFLAMMATORY BOWEL DISEASE

INFLAMMATORY BOWEL DISEASE 1. Medical Condition INFLAMMATORY BOWEL DISEASE (IBD) specifically includes Crohn s disease (CD) and ulcerative colitis (UC) but also includes IBD unclassified (IBDu), seen in about 10% of cases. These

More information

What do we need for diagnosis of IBD

What do we need for diagnosis of IBD What do we need for diagnosis of IBD Kaichun Wu Dept. of Gastroenterology, Xijing Hospital Fourth Military Medical University Xi an an,, China In China UC 11.6/10 5,CD 1.4/10 5 Major cause of chronic diarrhea

More information

Crohn s Disease. Resident Lecture 1/17/19

Crohn s Disease. Resident Lecture 1/17/19 Crohn s Disease Resident Lecture 1/17/19 Objectives Features/Classification of Crohn s Disease Medical Treatment Surgical Indications Surgical Considerations 2 Case 25 yo F presents to your office with

More information

Case Report Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent

Case Report Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent Gastroenterology Research and Practice Volume 2010, Article ID 860394, 4 pages doi:10.1155/2010/860394 Case Report Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent Jessica

More information

Achieving Success in Ulcerative Colitis: the Role of Infliximab

Achieving Success in Ulcerative Colitis: the Role of Infliximab Achieving Success in Ulcerative Colitis: the Role of Infliximab Dr Gill Watermeyer IBD clinic Groote Schuur Hospital 17 th August 2012 Inflammatory Bowel Disease Crohn s disease and ulcerative colitis

More information

Current management options and recent advances in IBD

Current management options and recent advances in IBD n DRUG REVIEW Current management options and recent advances in IBD Ben Warner BSc, MRCP and Peter Irving MA, MD, FRCP SPL The advent of biological therapies has revolutionised the management of inflammatory

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 20 October 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 20 October 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 20 October 2010 MEZAVANT LP 1200 mg, prolonged-release gastro-resistant tablets B/60 (CIP code: 378 689-2) Applicant

More information

Guideline scope Diverticular disease: diagnosis and management

Guideline scope Diverticular disease: diagnosis and management NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Diverticular disease: diagnosis and management The Department of Health in England has asked NICE to develop a clinical guideline on diverticular

More information

Who gets EIMs? Dr Tim Orchard St Mary s Hospital & Imperial College London

Who gets EIMs? Dr Tim Orchard St Mary s Hospital & Imperial College London Who gets EIMs? Dr Tim Orchard St Mary s Hospital & Imperial College London Background Extraintestinal manifestations of IBD are well recognised. They include:- Arthritis - peripheral and axial Eye complications

More information

LYMPHOMA COMPLICATING ULCERATIVE COLITIS

LYMPHOMA COMPLICATING ULCERATIVE COLITIS LYMPHOMA COMPLICATING ULCERATIVE COLITIS Pages with reference to book, From 37 To 39 Syed Hasnain Ali Shah, Abdul Haleem Khan, Ashfaque Ahmed ( Departments of Medicine, The Aga Khan University Hospital,

More information

Implementation of disease and safety predictors during disease management in UC

Implementation of disease and safety predictors during disease management in UC Implementation of disease and safety predictors during disease management in UC DR ARIELLA SHITRIT DIGESTIVE DISEASES INSTITUTE SHAARE ZEDEK MEDICAL CENTER JERUSALEM Case presentation A 52 year old male

More information

results from a regional patient group from the county of Copenhagen

results from a regional patient group from the county of Copenhagen Gut, 1985, 26, 158-163 Long term prognosis in ulcerative colitis based on results from a regional patient group from the county of Copenhagen C HENDRIKSEN, S KREINER, AND V BINDER From the Medical-Gastroenterological

More information

Algorithm for managing severe ulcerative colitis

Algorithm for managing severe ulcerative colitis Tropical Gastroenterology 2014;Suppl:S40 44 Algorithm for managing severe ulcerative colitis Vineet Ahuja 1, Ajay Kumar 2, Rakesh Kochhar 3 ABSTRACT Dept of Gastroenterology, 1 All India Institute of Medical

More information

WHAT IS ULCERATIVE COLITIS?

WHAT IS ULCERATIVE COLITIS? 235 60th Street, West New York, NJ 07093 T: (201) 854-4646 F: (201) 854-4647 810 Main Street, Hackensack, NJ 07601 T: (201) 488-0095 Ulcerative Colitis WHAT IS ULCERATIVE COLITIS? Ulcerative colitis is

More information

Research Article Temporary Fecal Diversion in the Management of Colorectal and Perianal Crohn s Disease

Research Article Temporary Fecal Diversion in the Management of Colorectal and Perianal Crohn s Disease Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2015, Article ID 286315, 5 pages http://dx.doi.org/10.1155/2015/286315 Research Article Temporary Fecal Diversion in the Management

More information

Incidence and Prevalence of Ulcerative Colitis and Crohn's Disease in the County of Copenhagen, 1962 to 1978

Incidence and Prevalence of Ulcerative Colitis and Crohn's Disease in the County of Copenhagen, 1962 to 1978 GASTROENTEROLOGY 182;83:53-8 and Prevalence of Ulcerative Colitis and Crohn's Disease in the County of Copenhagen, 12 to 178 VIBEKE BINDER, H. BOTH, P. K. HANSEN, C. HENDRIKSEN, S. KREINER and K. TORP-PEDERSEN

More information

Proctocolitis and Crohn's disease of the colon:

Proctocolitis and Crohn's disease of the colon: and of the colon: a comparison of the clinical course J. E. LENNARD-JONES, JEAN K. RITCHIE, AND W. J. ZOHRAB From St Mark's Hospital, London Gut, 1976, 17, 477-482 SUMMARY This study suggests that proctocolitis

More information

Ileo-rectal anastomosis for Crohn's disease of

Ileo-rectal anastomosis for Crohn's disease of Ileo-rectal anastomosis for Crohn's disease of the colon W. N. W. BAKER From the Research Department, St Mark's Hospital, London Gut, 1971, 12, 427-431 SUMMARY Twenty-six cases of Crohn's disease of the

More information

Diseases of the Colon. Jack Bragg, D.O., F.A.C.O.I.

Diseases of the Colon. Jack Bragg, D.O., F.A.C.O.I. Diseases of the Colon Jack Bragg, D.O., F.A.C.O.I. I have no disclosures I work for the Curators of the University of Missouri Inflammatory Bowel Disease ULCERATIVE COLITIS CROHN S DISEASE Transmural Inflammation

More information

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel

More information

Management of the Hospitalized IBD Patient. Drew DuPont MD

Management of the Hospitalized IBD Patient. Drew DuPont MD Management of the Hospitalized IBD Patient Drew DuPont MD Ulcerative Colitis: Indications for Admission Severe ulcerative colitis Frequent loose bloody stools ( 6 per day) Severe cramps Systemic toxicity:

More information

Clinical Trials in IBD. Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases

Clinical Trials in IBD. Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases Clinical Trials in IBD Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases Objectives Today s discussion will address the following topics: Similarities and differences between Crohn

More information

Does Fecal Microbiota Transplantation Cause Clinical Remission in Patients with Ulcerative Colitis?

Does Fecal Microbiota Transplantation Cause Clinical Remission in Patients with Ulcerative Colitis? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 12-2017 Does Fecal Microbiota Transplantation

More information

ABC of Colorectal Diseases

ABC of Colorectal Diseases ABC of Colorectal Diseases NON-SPECIFIC INFLAMMATORY BOWEL DISEASE S Pettit, M H Irving Non-specific inflammatory bowel diseases are those for which there is no discernible aetiological agent. The two

More information

What is ulcerative colitis?

What is ulcerative colitis? What is ulcerative colitis? Ulcerative colitis is a disease that causes inflammation and sores, called ulcers, in the lining of the rectum and colon. Ulcers form where inflammation has killed the cells

More information

Ulcerative Colitis. ulcerative colitis usually only affects the colon.

Ulcerative Colitis. ulcerative colitis usually only affects the colon. Ulcerative Colitis Introduction Ulcerative colitis is an inflammatory bowel disease. It is one of the 2 most common inflammatory bowel diseases. The other one is Crohn s disease. Ulcerative colitis and

More information

SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017

SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017 SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017 Leading the Microbiome Revolution Forward Looking Statements Some of the statements in this presentation

More information

Ulcerative colitis (UC) is a. The Patient with Newly Diagnosed Ulcerative Colitis: Anticipating the Questions and Individualizing the Answers

Ulcerative colitis (UC) is a. The Patient with Newly Diagnosed Ulcerative Colitis: Anticipating the Questions and Individualizing the Answers The Patient with Newly Diagnosed Ulcerative Colitis: Anticipating the Questions and Individualizing the Answers James Gregor, MD, Division of Gastroenterology, The University of Western Ontario, London,

More information

Mohamed EL-hemaly Gastro- intestinal surgical center, Mansoura University.

Mohamed EL-hemaly Gastro- intestinal surgical center, Mansoura University. Mohamed EL-hemaly Gastro- intestinal surgical center, Mansoura University. Chronic transmural inflammatory process of the bowel & affects any part of the gastro -intestinal tract from the mouth to the

More information

P a g e 1. Inflammatory Bowel Disease Guidelines

P a g e 1. Inflammatory Bowel Disease Guidelines P a g e 1 Inflammatory Bowel Disease Guidelines Introduction Inflammatory bowel disease (IBD) is a chronic inflammatory disease affecting the gastrointestinal (GI) system. It is comprised of two major

More information

Moderately to severely active ulcerative colitis

Moderately to severely active ulcerative colitis Adalimumab in the Treatment of Moderate-to-Severe Ulcerative Colitis: ULTRA 2 Trial Results Sandborn WJ, van Assche G, Reinisch W, et al. Adalimumab induces and maintains clinical remission in patients

More information

Response to First Intravenous Steroid Therapy Determines the Subsequent Risk of Colectomy in Ulcerative Colitis Patients

Response to First Intravenous Steroid Therapy Determines the Subsequent Risk of Colectomy in Ulcerative Colitis Patients Response to First Intravenous Steroid Therapy Determines the Subsequent Risk of Colectomy in Ulcerative Colitis Patients Tamás Molnár 1, Klaudia Farkas 1, Tibor Nyári 2, Zoltán Szepes 1, Ferenc Nagy 1,

More information

Ulcerative Colitis after Multidisciplinary Treatment for Colorectal Cancer with Multiple Liver Metastases : A Case Report

Ulcerative Colitis after Multidisciplinary Treatment for Colorectal Cancer with Multiple Liver Metastases : A Case Report Showa Univ J Med Sci 29 3, 315 319, September 2017 Case Report Ulcerative Colitis after Multidisciplinary Treatment for Colorectal Cancer with Multiple Liver Metastases : A Case Report Kodai TOMIOKA 1

More information

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital Aims To understand the aetiology of IBD To understand the impact that

More information

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS Target Audience: Physicians, Physician Assistants, Nurse Practitioners and Nurses impacted by the protocol. Scope/Patient Population: All adult

More information

Understanding Learning is the first step to getting help.

Understanding Learning is the first step to getting help. Understanding Inflammatory Bowel Disease (IBD) Learning is the first step to getting help. This booklet has been created through an educational grant provided by Fulford India Ltd., A subsidiary of Schering-Plough

More information

complicating inflammatory bowel disease

complicating inflammatory bowel disease Gut, 1982, 23, 410-414 Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease M R B KEIGHLEY*, DENISE YOUNGS, MARGARET JOHNSON, R N ALLAN, and D W BURDON From The General

More information

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD How do I choose amongst medicines for inflammatory bowel disease Maria T. Abreu, MD Overview of IBD Pathogenesis Bacterial Products Moderately Acutely Inflamed Chronic Inflammation = IBD Normal Gut Mildly

More information

Understanding Inflammatory Bowel Diseases (IBD):

Understanding Inflammatory Bowel Diseases (IBD): Understanding Inflammatory Bowel Diseases (IBD): What Every Patient Needs to Know William H Holderman, MD Digestive Health Specialists Tacoma, WA Today s Objectives Define IBD, its potential causes and

More information

Management of Gallstone Pancreatitis: Effects of Deviation from Clinical Guidelines

Management of Gallstone Pancreatitis: Effects of Deviation from Clinical Guidelines Management of Gallstone Pancreatitis: Effects of Deviation from Clinical Guidelines Kevin Sargen, Andrew N Kingsnorth Department of Surgery, Plymouth Postgraduate Medical School, Derriford Hospital. Plymouth.

More information

Treatment Goals. Current Therapeutic Pyramids Crohn s Disease Ulcerative Colitis 11/14/10

Treatment Goals. Current Therapeutic Pyramids Crohn s Disease Ulcerative Colitis 11/14/10 Current Management of IBD: From Conventional Agents to Biologics Stephen B. Hanauer, M.D. University of Chicago Treatment Goals Induce and maintain response/ remission Prevent complications Improve quality

More information

As clinicians we would all agree that the goal for our

As clinicians we would all agree that the goal for our CURRENT CONTROVERSIES: PRO, CON, AND BALANCE Controversies in Mucosal Healing in Ulcerative Colitis Sunanda Kane, MD,* Frances Lu, MD, Asher Kornbluth, MD, Dahlia Awais, MD, and Peter D.R. Higgins, MD,

More information

Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis

Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis Journal of Crohn s and Colitis (2007) 1, 21 27 available at www.sciencedirect.com Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis N. Eleftheriadis

More information

DIVERTICULOSIS MEDICAL AND SURGICAL MANAGEMENT. Simon Radley Consultant Surgeon March 2013

DIVERTICULOSIS MEDICAL AND SURGICAL MANAGEMENT. Simon Radley Consultant Surgeon March 2013 DIVERTICULOSIS MEDICAL AND SURGICAL MANAGEMENT Simon Radley Consultant Surgeon March 2013 Definitions Diverticulosis: presence of diverticulae Diverticular disease: diverticulae associated with symptoms

More information

Clinical Study Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis

Clinical Study Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2013, Article ID 192794, 6 pages http://dx.doi.org/10.1155/2013/192794 Clinical Study Clinical Study of the Relation between

More information

CROHN S DISEASE. The term "inflammatory bowel disease" includes Crohn's disease and the other related condition called ulcerative colitis.

CROHN S DISEASE. The term inflammatory bowel disease includes Crohn's disease and the other related condition called ulcerative colitis. CROHN S DISEASE What does it consist of? Crohn s disease is an inflammatory process that affects mostly to the intestinal tract, although it can affect any other part of the digestive apparatus from the

More information

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003 Surgical Management of IBD Val Jefford Grand Rounds October 14, 2003 Introduction Important Features Clinical Presentation Evaluation Medical Treatment Surgical Treatment Cases Overview Introduction Two

More information

Diarrhoea for the Acute Physician

Diarrhoea for the Acute Physician Diarrhoea for the Acute Physician STEPHEN INNS GASTROENTEROLOGIST AND PHYSICIAN HUTT VALLEY DHB August 2013 Outline Case History 1 Initial assessment of acute diarrhoea Management of fulminant UC Management

More information

Review article: the long-term management of ulcerative colitis

Review article: the long-term management of ulcerative colitis Aliment Pharmacol Ther 2004; 20 (Suppl. 4): 97 101. Review article: the long-term management of ulcerative colitis S. B. HANAUER Section of Gastroenterology, University of Chicago, Chicago, IL, USA SUMMARY

More information

Inflammatory Bowel Disease

Inflammatory Bowel Disease Inflammatory Bowel Disease Objectives: NOT FOUND. Team Members: Shrouq alsomali + Basel almeflh + Alaa alaqeel + Raneem alghamdi Team Leader: Haneen Alsubki Revised By: Maha AlGhamdi Resources: 435 team

More information

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel

More information

Crohn s disease is a chronic idiopathic disease of the

Crohn s disease is a chronic idiopathic disease of the GASTROENTEROLOGY 1999;117:49 57 Clinical Course and Costs of Care for Crohn s Disease: Markov Model Analysis of a Population-Based Cohort MARC D. SILVERSTEIN,*,, EDWARD V. LOFTUS, Jr., WILLIAM J. SANDBORN,

More information

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency SD, male 40 yrs. old. (680718M467.) -2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine -June 2008: Recurrence of rectal blood loss and urgency Total colonoscopy: ulcerative rectitis,

More information

Review article: induction therapy for patients with active ulcerative colitis

Review article: induction therapy for patients with active ulcerative colitis Alimentary Pharmacology & Therapeutics Review article: induction therapy for patients with active ulcerative colitis S. P. L. TRAVIS John Radcliffe Hospital and Linacre College, Oxford, UK Correspondence

More information

Protocol for the management of acute severe ulcerative colitis in children

Protocol for the management of acute severe ulcerative colitis in children Protocol for the management of acute severe ulcerative colitis in children Introduction: Paediatric UC is severe and more extensive than adult onset UC with 6-8% presenting as pancolitis (1,2) Within five

More information

Title: Author: Journal:

Title: Author: Journal: IMPORTANT COPYRIGHT NOTICE: This electronic article is provided to you by courtesy of Ferring Pharmaceuticals. The document is provided for personal usage only. Further reproduction and/or distribution

More information

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE The diagnosis of CDI should be based on a combination of clinical and laboratory findings. A case definition for the usual

More information

Diagnostic techniques for surveillance of dysplasia

Diagnostic techniques for surveillance of dysplasia January 27th 2017, 8th Gastro Foundation Weekend for Fellows; Spier Hotel & Conference Centre, Stellenbosch Diagnostic techniques for surveillance of dysplasia Gerhard Rogler, Department of Gastroenterology

More information

Year 2002 Paper two: Questions supplied by Jo 1

Year 2002 Paper two: Questions supplied by Jo 1 Year 2002 Paper two: Questions supplied by Jo 1 29) A 54 year old man with colonic Crohn s disease is in remission following an 8 week course of prednisolone. Which one of the following medications is

More information

This program is supported by an educational grant from Janssen Biotech Inc., Shire, Inc., and a sponsorship from Takeda

This program is supported by an educational grant from Janssen Biotech Inc., Shire, Inc., and a sponsorship from Takeda This program is supported by an educational grant from Janssen Biotech Inc., Shire, Inc., and a sponsorship from Takeda Today s Presenter Adam S. Cheifetz, MD Director, Center for Inflammatory Bowel Disease

More information

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS Target Audience: Physicians, Physician Assistants, Nurse Practitioners and Nurses impacted by the protocol. Scope/Patient Population: All adult

More information

INFLAMMATORY BOWEL DISEASE

INFLAMMATORY BOWEL DISEASE National University Faculty of Medicine INFLAMMATORY BOWEL DISEASE Gehan M. Osman, MD. MBBS Pediatrician Jaffar Ibn Auf Specialized Hospital EDUCATIONAL OBJECTIVES Definitions and spectrum of (IBD) Epidemiology

More information

Crohn's Disease. What causes Crohn s disease? What are the symptoms?

Crohn's Disease. What causes Crohn s disease? What are the symptoms? Crohn's Disease Crohn s disease is an ongoing disorder that causes inflammation of the digestive tract, also referred to as the gastrointestinal (GI) tract. Crohn s disease can affect any area of the GI

More information

ORIGINAL ARTICLE. Surgery for Ulcerative Colitis in Elderly Persons. Changes in Indications for Surgery and Outcome Over Time

ORIGINAL ARTICLE. Surgery for Ulcerative Colitis in Elderly Persons. Changes in Indications for Surgery and Outcome Over Time ORIGINAL ARTICLE Surgery for Ulcerative Colitis in Elderly Persons Changes in Indications for Surgery and Outcome Over Time Gidon Almogy, MD; David B. Sachar, MD; Carol A. Bodian, DrPH; Adrian J. Greenstein,

More information

Mimics of Inflammatory Bowel Disease. Dr Catriona McKenzie Royal Prince Alfred Hospital, Camperdown

Mimics of Inflammatory Bowel Disease. Dr Catriona McKenzie Royal Prince Alfred Hospital, Camperdown Mimics of Inflammatory Bowel Disease Dr Catriona McKenzie Royal Prince Alfred Hospital, Camperdown Mimics of IBD: Overview Infections Drugs Autoimmune Other Infections Diagnostic Histopathology, 2015 Case

More information

THE OUTCOME OF INFLAMMATORY BOWEL DISEASE

THE OUTCOME OF INFLAMMATORY BOWEL DISEASE THE OUTCOME OF INFLAMMATORY BOWEL DISEASE R G Farmer SING MED J. 1989; No 3: 89-93 Crohn's disease and ulcerative colitis have become among the most frequently encountered chronic digestive diseases. Two

More information

Randomised clinical trial: delayed-release oral mesalazine 4.8 g day vs. 2.4 g day in endoscopic mucosal healing ASCEND I and II combined analysis

Randomised clinical trial: delayed-release oral mesalazine 4.8 g day vs. 2.4 g day in endoscopic mucosal healing ASCEND I and II combined analysis Alimentary Pharmacology and Therapeutics Randomised clinical trial: delayed-release oral mesalazine 4.8 g day vs. 2.4 g day in endoscopic mucosal healing ASCEND I and II combined analysis G. R. Lichtenstein*,

More information

Dr David Rowbotham. The Leeds Teaching Hospitals NHS Trust NHS

Dr David Rowbotham. The Leeds Teaching Hospitals NHS Trust NHS Dr David Rowbotham The Leeds Teaching Hospitals NHS Trust NHS Useful Titbits from the World of Gastroenterology David Rowbotham Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology

More information